36 employees
NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease.
2020
$47M
from 5 investors over 5 rounds
NextRNA Therapeutics raised $47M on March 1, 2022
Investors: Circle Squared Alternative Investments, Willett Advisors LLC, Evans Capital, Lightchain Capital LLC and COBRO VENTURES, INC